News | July 29, 2009

Calypso Touts Deal to Develop RT Cancer Treatment with Varian

July 29, 2009 – At the AAPM 51st Annual Meeting, Calypso Medical Technologies touted its strategic development agreement with Varian Medical Systems to jointly develop products integrating its Calypso System with Varian’s radiotherapy treatment technologies.

Calypso Medical’s proprietary technology utilizes miniature implanted transponders to provide precise, continuous, real-time information about the location of the tumor target during external beam radiation therapy. Calypso’s technology provides continuous tumor position information designed to enable the correct radiation dose to be delivered to the tumor while minimizing the amount of radiation misapplied to normal tissue.

The Calypso technology is complementary to Varian’s state-of-the-art technology for delivering intensity-modulated radiotherapy (IMRT), including RapidArc radiotherapy. Varian is the market share leader for linear accelerators worldwide.

“This strategic development agreement will facilitate advanced treatment capabilities through the integration of the Calypso System with Varian’s market-leading radiotherapy technologies,” said Eric R. Meier, president and chief executive officer of Calypso Medical. “We believe these efforts may prove beneficial for prostate patients as well as some of the more difficult radiation therapy targets such as pancreas and lung. In the near term, two exciting joint development efforts will integrate the motion management capabilities of our Calypso System with Varian’s state-of-the-art treatment platform. This agreement will provide the framework for the joint development of Real-Time MLC Tracking, a future capability* demonstrated by both companies last year, which causes the radiation beam to move in concert with the tumor target based on real-time tracking data provided by the Calypso System.”

Under the terms of the agreement, the two companies will jointly develop products that integrate the Calypso System with Varian’s technologies. Further terms of the agreement were not disclosed.

* This technology is a concept device under development and not available for sale.

For more information: www.calypsomedical.com

Related Content

Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.
Videos | Lung Cancer | January 29, 2019
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D., prof
Southern Asia's First Proton Therapy Center Begins Treatments
News | Proton Therapy | January 28, 2019
IBA (Ion Beam Applications SA) announced the opening of the Apollo Proton Cancer Centre in Chennai, India, and the...
Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus